Desmin, the muscle-specific intermediate filament protein, is a major target in dilated cardiomyopathy and heart failure in humans and mice. The hallmarks of desmin-deficient (des 2/2 ) mice pathology include pronounced myocardial degeneration, extended fibrosis, and osteopontin (OPN) overexpression. We sought to identify the molecular and cellular events regulating adverse cardiac remodelling in des 2/2 mice and their potential link to OPN.
Introduction
The intermediate filament protein desmin is a primary target for cardiomyopathy (CM) and heart failure (HF). 1 Over 40 desmin mutations can cause skeletal and/or cardiac myopathies. Dilated cardiomyopathy (DCM), the main cause of HF, is the most frequent desmin-related CM followed by restrictive CM, 2 hypertrophic CM, arrhythmogenic right ventricular dysplasia, and their combinations. 3 Moreover, recent studies demonstrate that tumor necrosis factor-a (TNF-a)-induced HF occurs, to a great extent, through caspase cleavage of desmin and aggregate formation, leading to cardiomyocyte structural defects and death. 4 In addition, the R120G mutation of aB-crystallin causes the same desminrelated CM, with progressive DCM and HF. 5 Importantly, human DCM-linked failing hearts, regardless of mutations, display ultrastructural abnormalities common to both desmin-deficient heart 6 and the TNF-a-induced mouse HF. 4, 7 We have previously shown that desmin deficiency leads to severe skeletal muscle and myocardial defects, 8, 9 including impaired mitochondrial morphology, positioning, and respiratory † Contributed equally.
function. 6 The myocardial degeneration is accompanied by inflammation, fibrosis, calcification, developing over time DCM and eventually HF. 8, 10, 11 Mitochondrial-regulated cell death is an important target of des 2/2 CM, 12 however, additional and/or complementary mechanisms, particularly extrinsic pathways and potential contributing mediators, remain largely unknown. Desmin deficiency is also characterized by myocardial overexpression of osteopontin (OPN). 11 Osteopontin is a matricellular protein and a cytokine induced upon tissue injury and remodelling of various organs, including human failing heart. 13 Its action may be pleiotropic and tissue-specific, exerting even opposite effects during disease. 14 Studies on its role in heart pathology have been largely limited to experimentally induced injury under OPN deficiency, a condition reported to confer protection to subsequent heart dysfunction in some settings, 15 but to induce it in others. 16, 17 Thus, the use of genetic models of HF to further understand its importance and mode of action is obligatory.
In an effort to further understand the molecular and cellular events regulating adverse cardiac remodelling and their potential link to OPN, we used the des 2/2 HF model. In addition to OPN, microarray analysis led to identification of several key candidate modulators, expressed by inflammatory infiltrates in des
hearts. In this report, we demonstrate that OPN plays a substantial role in des 2/2 cardiac fibrosis and dysfunction, probably by affecting the expression of other molecules, such as the important remodelling modulator galectin-3.
Methods Animals
The procedures for the care and treatment of animals were according to institutional guidelines following those of Association for the Assessment and Accreditation of Laboratory Animal Care (AAALAC) and the recommendations of Federation of European Laboratory Animal Science Association (FELASA). Desmin-deficient mice were generated as described in 129Sv genetic background. 8 Mice lacking OPN, kindly provided by Dr Lucy Liaw (Maine Medical Center, Scarborough, ME, USA), 18 were backcrossed for more than seven generations to obtain a C57BL/6 background. 
Muscle morphology
Tongues from 8 to 10-month-old mice (n ≥ 3 per genotype) were paraffin-embedded and muscle morphology was determined by haematoxylin -eosin (H&E) staining, as described. 8 Analysis of cardiac inflammation, apoptosis, and fibrosis
Analysis and assessment of cardiac inflammation, apoptosis, and fibrosis was conducted as described in Supplementary material online, Methods.
Echocardiography M-mode echocardiography was performed as described in Panagopoulou et al. 4 and Supplementary material online, Methods to measure left ventricular (LV) end-diastolic diameter (EDD), LV end-systolic diameter (ESD), and LV posterior wall thickness at diastole (PWT) and to calculate the ratio of LV radius to PWT (r/h) and the percentage of LV fractional shortening FS(%).
Microarrays
Total RNA from hearts of 3-month-old des 2/2 (n ¼ 3) and wt (n ¼ 3)
129Sv male mice was pooled, processed, and hybridized to Affymetrix 430 2.0 microarrays at the MIT BioMicrocenter facility (Boston, MA, USA) and microarray analysis was performed to identify significantly changed genes, as described in Supplementary material online, Methods.
Quantitative RT-PCR
cDNA generated from total heart RNA from wt (n ¼ 6), des
(n ¼ 6), or des 2/2 OPN 2/2 (n ¼ 4) 3-month-old male mice was subjected to SYBR Green-based real-time PCR analysis, as described in Supplementary material online, Methods. Similar procedures were followed to compare gene expression among des 2/2 (n ¼ 4) and
Osteopontin, galectin-3, osteoactivin, and matrix metallopeptidase 12 expression studies
In situ hybridization and immunostaining
Osteopontin and osteoactivin (OA)-specific riboprobes were used for In situ hybridization (ISH), whereas single and double immunofluorescence and immunohistochemistry were used for localization studies, as described in Supplementary material online, Methods.
Heart infiltrate analysis
Following digestion of inflamed parts of des 2/2 hearts with collagenase, immunocyte-enriched single-cell suspensions were obtained and further cytospun to study OA-CD11b co-localization. Alternatively, CD11b + and CD11b 2 fractions were isolated by magnetic bead cell fractionation and OA expression was studied by RT -PCR, as described in Supplementary material online, Methods.
Immunoblotting
Pooled extracts from 2 to 4 des 2/2 or des 2/2 OPN 2/2 hearts of similar inflammatory lesions and age-matched wt hearts were used to assess cardiac galectin-3 levels by western blot, as described in Supplementary material online, Methods.
Galectin-3 expression studies in murine peritoneal macrophages
Peritoneal macrophages, obtained following intraperitoneal injection of thioglycollate broth, were stained and subjected to flow cytometry against galectin-3/Mac2 and CD45, or cultured with or without interferon-g (100 units/mL) and lipopolysaccharide (100 pg/mL), and galectin-3 levels in their conditioned media were evaluated with western blotting as described in Supplementary material online, Methods.
Neutrophil inhibition studies
Peripheral Ly6G + neutrophils were inhibited in 14-day-old des Figure S1 and Results).
To identify the pathways and modifiers involved in the long-term des 2/2 adverse remodelling, omitting the transient interference of the acute inflammatory phase, we analysed genome-wide expression in 3-month-old animals: 284 transcripts were significantly up-regulated in des 2/2 hearts, when compared with wt controls (Supplementary material online, Results, Figure S2 , and Tables  S1 -3) . Even in the less dynamic phase that follows acute inflammation, the majority (n ¼ 64) of the up-regulated genes are related to inflammation and/or immune response, whereas a considerable part (n ¼ 27) is associated with tissue remodelling and angiogenesis. In addition, genes encoding for mitochondrial proteins (n ¼ 10), or molecules involved in muscle homeostasis and contraction (n ¼ 5), calcium homeostasis (n ¼ 2), lipid metabolism and homeostasis (n ¼ 11), oxidation and reduction (n ¼ 11), neuronal homeostasis (n ¼ 11), transcriptional regulation (n ¼ 11), signal transduction (n ¼ 18), cell death/apoptosis (n ¼ 2), and cell cycle and proliferation (n ¼ 3) were also induced. Whereas 96% of these transcripts were up-regulated 2 to 10-fold (median 2.8-fold; fold-values are from Supplementary material online, Table S1 representing the ratio of the average of the expression values obtained from the des 2/2 vs. wt), four of them, known to be expressed by inflammatory cells, showed a dramatic up-regulation (OPN: 226×, OA: 160×, matrix metallopeptidase 12 (MMP12): 98×, and galectin-3: 26×) further underlining the prominent activation of inflammatory pathways. Since these genes have been shown to be involved in tissue remodelling, 20 -23 we further focused on the study of their expression, localization, and potential contribution to des 2/2 pathology.
Cardiac overexpression of osteopontin, galectin-3, osteoactivin, and matrix metallopeptidase-12 is due to inflammatory infiltrates
We have previously shown that OPN forms high-molecular weight deposits co-localized with calcium within degenerated des 2/2 myocardium. 11 To determine the source of cells responsible for the elevated OPN, we used ISH and demonstrated that OPN mRNA was only within cells infiltrating the des 2/2 heart and not in cardiomyocytes (Figure 2A-F) . Overexpression of galectin-3 was also evidenced by strong-specific signal localized within the infiltrates ( Figure 2G and H ). Both ISH and immunostaining showed that the less well-studied OA was also expressed by cells infiltrating the des 2/2 myocardium, as was also the case for
We further undertook co-localization studies to identify the cell population/s responsible for the overproduction of these molecules. As expected from the above, OPN protein was deposited within cardiomyocyte-depleted areas and not in intact myocardium ( Figure 3A) . The pattern of OPN staining indicated an extracellular deposition within CD11b + infiltrates ( Figure 3C and D), implying that the immunocytes secreted this matricellular protein in a form allowing its interstitial deposition. Galectin-3 protein was also observed within cardiomyocyte-depleted infiltrates ( Figure 3A) , but co-localizing with CD11b + cells ( Figure 3C and D) . On the other hand, OA partly co-localized with CD11b-positive staining ( Figure 3C ). Further studies revealed a subset of infiltrating CD11b + cells to preferentially express intracellular OA ( Figure 3D) . Finally, MMP12-positive structures were found in cardiomyocyte-depleted, CD11b
+ -enriched infiltrated areas.
aSMA + myofibroblasts, although observed in the vicinity, were not identified as an additional source of these molecules ( Figure 3B ).
Improved cardiac function and decreased fibrotic lesions in osteopontin-deficient des 2/2 hearts Regulation of adverse remodelling by osteopontin developed, bred, and reproduced normally. Osteopontin-deficiency did not affect the features of muscle degeneration 8 observable in des 2/2 skeletal muscles ( Figure 4A) . In contrast, when we assessed the systolic function impairment previously reported to be observed in 12-month-old des 2/2 hearts 10 by echocardiography, we found a significant 53% improvement in LV systolic function (%FS) in des 2/2 OPN 2/2 when compared with des 2/2 ( Figure 4B and Table 1 ). LV dilatation was reduced by 29%, with EDD almost reaching wt values ( Figure 4C ). An important 40% improvement in ESD was measured which although worse did not statistically differ from that of the wt mice ( Figure 4D ). This, along with a 30% improvement of the posterior wall thickening ( Figure 4E ) clearly showed a benefit in systolic function of the des 2/2 mice under OPN deficiency. Finally, the r/h ratio, an indicator of LV wall stress, was significantly lower in these mice ( Figure 4F ).
To examine whether the improvement in function parallels amelioration in myocardial damage, we evaluated cardiac fibrosis and found it to be significantly less in des 2/2 OPN 2/2 than des 2/2 mice ( Figure 4G ). Quantification by two independent methods in a group of littermates revealed 20% reduction by conventional grading ( Figure 4H ; 3.22+ 0.17 vs. 2.57 + 0.12, P ¼ 0.006), and 32% by software-based analysis ( Figure 4I ; 11.60 + 1.53% vs. 7.85 + 0.94%, P ¼ 0.049). Similarly, analysis of an independent group of older, agematched mice revealed 22% ( Figure 4K ; 3.31 + 0.14 vs. 2.57 + 0.10, P , 0.001) and 44% reduction ( Figure 4L ; 11.62 + 1.36% vs. 6.53 + 0.55%, P ¼ 0.001), respectively. The altered fibrotic responses in the absence of OPN did not correlate to the extent and/or resolution of the acute, remodelling-initiating, inflammatory phase or to the degradation of matrix components under OPN deficiency, as these parameters remained unchanged among des Osteopontin deficiency is linked to extensive decrease in the overexpression of galectin-3
(B -F): Group data and P-values for comparisons of M-mode echocardiograms for %FS(B), LVEDD(C), LVESD(D), PWT(E), and r/h ratio(F) of 12-month-old des
We next asked whether OPN affects the expression of galectin-3, OA, or MMP-12. We found that although the expression of these genes in des 2/2 OPN 2/2 hearts was induced when compared with wt hearts, this induction was dramatically lower when compared with the considerable up-regulation observed in des 2/2 hearts ( Table 2 and Figure 5A ). Specifically, galectin-3 was reduced by 78%, OA by 92%, and MMP-12 by 94%. In contrast, expression of the known fibrosis regulator TGF-b showed a modest increase when compared with wt but remained unchanged under OPN deficiency ( Figure 5B ), suggesting that TGF-b does not mediate OPN-dependent des 2/2 fibrosis.
Among the differentially regulated molecules, galectin-3 is the one showing the strongest association to fibrosis, 21, 24 the crucial parameter of the desmin-null cardiac dysfunction. Therefore, we further investigated the abundance of this protein along the inflammatory and the fibrotic phases of des 2/2 adverse remodelling.
Galectin-3 immunoreactivity appeared in the des 2/2 myocardium after the initiation of inflammation ( Figure 5C , lane 3) and its levels were lower in 3-month-old than in 20-25-day-old des 2/2 hearts ( Figure 5C , compare lane 6 to 3), probably reflecting regression of inflammation with age. Interestingly, des 2/2 OPN 2/2 hearts of similar inflammation severity were found to contain less galectin-3 than their des 2/2 counterparts at all ages examined ( Figure 5C , compare lane 4 to 3 and lane 7 to 6). We asked whether this difference would reflect a macrophage-specific defective galectin-3 expression pattern of des 2/2 OPN 2/2 infiltrates. To address this, we evaluated the Galectin-3/Mac2 + fraction of peritoneal macrophages isolated from OPN 2/2 and OPN 1/1 mice. We found, indeed, that considerably fewer cells with surface expression of galectin-3 were recruited in the peritoneum of OPN-deficient mice ( Figure 5D ). Moreover, cultured OPN-deficient macrophages secreted upon activation lower levels of galectin-3, when compared with those secreted by equal numbers of OPN +/+ macrophages ( Figure 5E , 35 + 7% reduction, as revealed by assessment of the relative band intensities). These results are consistent with the reduced galectin-3 levels observed in the des
heart. The recruitment and activation of other immunocytes could be also affected by OPN. 14, 25, 26 Therefore, to address the potential contribution of T-lymphocytes, also present in the des 2/2 heart (Supplementary material online, Figure S4A and B), in our DCM model, we crossed the des 2/2 with RAG1 2/2 mice, which lack mature lymphocytes. 19 Comparison of myocardial remodelling indices and expression profiles among des 2/2 RAG1 2/2 and des 2/2 at early and/or intermediate time points revealed that the absence of mature T-cells had no particular impact on fibrosis and the expression of OPN, galectin-3, and the other up-regulated genes (Supplementary material online, Figure S4 ). In contrast, the early inflammatory response was even higher under this condition (3.44 + 0.14 vs. 2.82 + 0.15, P ¼ 0.013), suggesting that T-cell populations may actually temper the innate inflammatory response, as observed in other experimental settings. 27 Moreover, inhibition Figure S4H ), overall suggesting that macrophage-related changes are stronger contributors to the des 2/2 remodelling.
Discussion
Here we identify that inflammatory mediators such as OPN are central players in adverse remodelling characterizing the des 20, 30 ). We showed that removal of OPN, by gene depletion, reduces fibrosis and improves the systolic properties of des 2/2 myocardium. This finding is strongly supported by recent data showing development of fibrosis and DCM following forced expression of OPN in cardiomyocytes. 26 Moreover, OPN up-regulation has been associated with increased collagen expression and/or deposition in DCM patients 31 and in animal models of induced heart injury. 16, 32 Particularly following myocardial infarction (MI), OPN is also overexpressed by the inflammatory infiltrate, mainly its macrophage compartment. 20 In agreement with our studies, following MI less collagen is deposited in the myocardium of OPN 2/2 mice when compared with wt ones; however, a protective action has been concluded for OPN in that case, 16, 33 but this was in hearts examined 14-28 days post-MI, a time point when collagen deposition is actually protective against metalloproteasedriven cardiac rupture and mortality.
On the other hand, the improvement of %FS in des 2/2 under OPN deficiency (53%) is similar to the level of reduction in fibrosis (up to 44%), whereas activity of myocardial metalloproteases remains unaffected. This finding suggests that OPN-mediated fibrosis in this model is closely associated with cardiac function impairment in the long term.
It also suggests that other OPN-independent mechanisms and factors are responsible for the remaining fibrosis and dysfunction, currently under investigation in our laboratory.
The profibrotic role of OPN in des 2/2 heart could be mediated by protection of cardiac fibroblasts from apoptosis 34 or by promotion of their differentiation into myofibroblasts. 35 Our data together with those of other investigators so far suggest that the effect of OPN on collagen production is not direct, 36 but most possibly mediated by galectin-3, which has been linked both to collagen production in the heart 21, 37 and myofibroblast transdifferentiation of liver stellate cells. 24 The secretion of galectin-3 by activated macrophages, the predominant immunocytes infiltrating the des 2/2 heart, allows its action in a paracrine manner on resident cardiac fibroblasts. Figure S5 ). The reduced galectin-3 expression by des 2/2 OPN 2/2 hearts does not seem to be attributed to a general alteration of severity or resolution rates of myocardial inflammation. The presence of less galectin-positive macrophages in OPN 2/2 infiltrates may reflect lower recruitment efficiency of galectin-positive macrophages, a change in macrophage function 39 and/or expression pattern of surface markers, including Mac-2/galectin-3, 40 or an altered differentiation state of the OPN-deficient macrophages. 41 An impaired NFkB activation, as is the case in bone marrow-derived OPN 2/2 macrophages, 42 has not been excluded. Its full elucidation may have impact in several monocyte/macrophage-dependent inflammatory states, but is beyond the scope of this article. Our novel finding that OPN regulates the release of galectin-3 by macrophages further implies that impairment in the paracrine action of galectin-3 may be also responsible, at least in part, for the diminished cardiac fibrosis observed in des 2/2 OPN 2/2 mice.
In contrast to the strong association of galectin-3 to fibrosis, MMP12 has not been reported to directly affect collagen production. MMP-12 could contribute to des 2/2 remodelling by cleaving OPN into products with altered properties in mediating tissue pathology, as recently shown in other settings. 43 On the other hand, the limited studies addressing OA suggest that it can exert anti-inflammatory actions targeting macrophages, 44 whereas it may protect against liver fibrosis. 22 Overall, published data suggest that in des 2/2 hearts MMP-12 may act as a mild contributor to fibrosis in parallel to galectin-3, whereas OA could inhibit inflammation and fibrosis. The elucidation of their respective role(s) is the subject of forthcoming studies in our laboratory.
Owing to the large numbers of animals used throughout the study (n . 300), in some experiments, when allowed, and due to ethical, space, and cost limitations, groups studied were consisted of less than six animals. Therefore, for some of the expression level comparisons described in the present study, the small sample size of animals could be a limitation, in particular, when applying a t-test or ANOVA with less than six animals in a group. However, in the RNA expression level comparisons described in Table 2 , this limitation is minimal, given that the differences between groups were high and the + SE values within a group comprised 7.3-18.4% of the mean values (average 11.4%).
In conclusion, among the cellular and molecular components identified here to be activated during inflammation and remodelling of desmin deficiency-associated CM, OPN promotes heart dysfunction at least by affecting the expression of galectin-3. Elucidation of mechanisms of des 2/2 remodelling may apply, apart from other models of inflammation-associated CMs, to most inflammation-linked diseases.
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